SciELO - Scientific Electronic Library Online

 
vol.47 issue1Evaluación de los mamógrafos en Costa RicaComposición, caracterización y potencial aterogénico de aceites, grasas y otros derivados producidos o comercializados en Costa Rica author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • Have no similar articlesSimilars in SciELO

Share


Acta Médica Costarricense

On-line version ISSN 0001-6002Print version ISSN 0001-6012

Abstract

SAENZ-CAMPOS, Desirée; TINOCO-MORA, Zahira  and  ROJAS-MORA, Laura M. Factores de riesgo para infarto agudo de miocardio y prescripción de medicamentos para prevención secundaria. Acta méd. costarric [online]. 2005, vol.47, n.1, pp.31-35. ISSN 0001-6002.

Objective: To describe some factors of coronary risk present in patients who survive a first acute myocardial infartion and the pharmacological treatment prescribed for secondary prevention. Methods: Observational, cross sectional and descriptive pilot study, information was obtained from the charts of 50 patients seen at 3 national hospitals. Results: 42 males and 8 women, age 63 ± 15 years, weight 67 ± 12 kg, Body Mass Index = 26.1 ± 2.1 kg/m2, 38% hypertensive, 22% diabetic (n = 8 smokers patients with diabetes+hypertension) and 34% smokers. Total cholesterol levels: 191 ± 45.7 mg/dL, cholesterol-LDL= 112 ± 33.8 mg/dL and cholesterol-HDL: 39.4 ± 8.26 mg/dL. The patients were prescribed: 92% antithrombotics drugs (predominated aspirin), 92% statins, 78 % beta- blockers (atenolol or carvedilol), 70% enalapril or losartan and 48% nitrates. Conclusions: this preliminary study indicateds that coronary disease appears in young adult, it’s most frequent in males and showeds modifiable factors of risks. Antithrombotics drugs, beta-blockers and statins are most frequently.

Keywords : infarto agudo de miocardio; prevención secundaria; colesterol; aspirina; atenolol; enalapril.

        · abstract in Spanish     · text in Spanish

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License